Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to related businesses based on the strength of its valuation, analyst recommendations, institutional ownership, earnings, profitability, dividends and risk. Analyst Ratings This is […]
Singular Genomics Systems, Inc Reports Recent Highlights and First Quarter 2022 Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 2,760,000 shares, an increase of 43.8% from the March 15th total of 1,920,000 shares. Approximately 9.0% of the company’s shares are sold short. […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) had its target price decreased by The Goldman Sachs Group from $17.00 to $11.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 109.13% from the […]